Biotage, LLC

Biotage, LLC, a Charlotte, North Carolina-based manufacturer of analytical chemistry equipment and laboratory consumables, operates as a prime contractor delivering analytical instrumentation, sample preparation systems, and chromatography equipment to federal agencies through small-business-set-aside and full-and-open purchase orders. The company qualifies as a small business under NAICS 334516 (Analytical Laboratory Instrument Manufacturing) and competes across both set-aside and unrestricted procurements, with set-asides representing roughly 10–15% of recent awards by count.

Biotage's federal footprint spans 447 recent awards with a combined potential value of $14.4 million, of which $13.2 million (92%) has been obligated, reflecting mature, transactional relationships with repeat customer agencies. The vendor operates exclusively as a prime contractor (446 of 447 awards) with a single sub-award to UT-Battelle LLC for a microwave peptide synthesizer at Oak Ridge National Laboratory. Biotage manufactures and delivers named product lines including TurboVap and TurboVap LV solvent evaporation systems, Horizon solid phase extractors, flash chromatography systems, Isolera purification systems, and Initiator+ microwave peptide synthesizers. Representative prime awards include a $286 thousand EPA Region 5 delivery order for four SPEDEX 5000 systems (April 2026), a $211 thousand EPA Region 9 Horizon 5000 and accessories order under total small business set-aside (May 2024), and a $167 thousand National Center for Advancing Translational Sciences service and maintenance agreement for microwave and sample preparation systems (June 2024).

Customer concentration is heavy and singular: the top five funding agencies account for 31% of awards by count but anchor 45% of combined potential value, with the Department of Health and Human Services dominating through three distinct customer segments. CDC Pittsburgh leads by dollar value (38 awards, $2 million combined potential value), followed by NIH Clinical Center (17 awards, $1.5 million) and FDA (40 awards, $1.2 million). EPA, across multiple regions, is the second-largest customer category overall, with Regional offices (Regions 1–9) collectively placing numerous orders for extraction and evaporation equipment. The Environmental Protection Agency's Office of Research and Development ranks among the top five customer agencies. Recent awards cluster around laboratory equipment procurement and service agreements for existing Biotage systems already installed at federal facilities — the sourcing pattern suggests established relationships anchored by capital equipment installed years ago, with follow-on consumables, maintenance, and service contracts renewing annually.

Biotage sits on one named parent vehicle: the HHS Indefinite Delivery Contract HHSN269201700015I, which carries seven task orders totaling $201 thousand in combined potential value. No GSA GWACs, BPAs, or agency-wide IDIQs appear in the vehicle footprint; purchases flow instead through direct agency purchase orders and simplified acquisitions. The vendor's category concentration reinforces its product-centric positioning: Analytical Laboratory Instrument Manufacturing accounts for 293 of 447 awards (66%), with Laboratory Equipment and Supplies the dominant PSC code (275 awards). Pump and pumping equipment, electronic equipment repair and maintenance, and merchant wholesale of professional supplies make up the remaining 15%.

Activity has contracted materially. The vendor recorded 24 awards in 2022, 14 in 2023, 13 in 2024, 7 in 2025, and 6 through mid-2026 (a steep downward trajectory). Nine awards carrying combined potential value of $572 thousand reach ultimate completion within the next twenty-four months, representing modest recompete exposure. The award stream consists almost entirely of firm-fixed-price purchase orders ranging from $3 thousand to $300 thousand per award, with no evidence of contract vehicles, task order structures, or dollar-ceiling contracts that would signal large ongoing engagements. Biotage's federal market position is that of a transactional equipment supplier with deep penetration in CDC and NIH laboratory procurement and modest EPA presence, competing predominantly full-and-open against other analytical equipment manufacturers rather than leveraging set-aside status as a strategic advantage.